Cheplapharm Arzneimittel GmbH

Deals

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
EUR300.0007May-30Sr. SecuredB2B+BB-FixedB100 a100.50 a4737.50%-100.50000
Tranche Comments
7 yr: First Pay: 2023-11-15; Redemption: 2026-05-15; Registration: 144A/Reg S; Comments: EUR300m (Upsized from EUR250m) across taps of 7.5% & 3mE+475 May 2030 snr sec RegS/144A. B2/B+/BB-. GloCo DB/JPM(B&D). IPTs 100 area (+/-0.25%) on both, price talk 100.50 area (+/-0.25) for min 250m fxd - up to 50m FRN. Launch 300m at 100.5, FRN withdrawn. DBR 0% 08/2030, B+ 473. 144a immed funge, RegS 40 day. FTT: 4:15pm. CoC: 101%. Equity Claw Back: Up to 40% at 107.5%, until May 15, 2026. MWC: B+50 bps. Call Schedule: 2026-05-15@103.75. 2027-05-15@101.875. 2028-05-15@100.0. Reset Date: 2026-05-15. LEI: 529900ONXKBELT7EW052;
Deal Comments
EUR300m tap of 7.5% due 5/15/2030
Guarantor(s)
Cheplafinance 2 Gmbh
Use of Proceeds
General corporate purposes and pay transaction-related fees and expenses
CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
YOC584.0004Jul-12Na. NzijazaT2J+EE-BznmxJIbn 7s7.50% s5237.50%-206.00000
FMD684.0009Aug-22Ti. TtmuitnZ2X+AA-Ujyawmde3nKd3hTd+475 k3fDt+475-3eUx+475-75.00000
Tranche Comments
7 pg: Redemption: 2026-05-15; Registration: 144J/Bzy Y; Comments: EPE750z 7SE3 msj xgv xrd ErnN/144P. U2/U+/UU-. SflElx Ugvd/OU(msj U&O)/QHU(PES U&O), QUx Ejsj/EUP/SN/OSS/Pgj. Ulsj 250z+. Pjsrj wjjxbrvx zjj 7x. OHPx msj zjj 7x. Hvjdr sgfo 7.5% gvrg. Egdgdj 425z gs 7.5%. PPP 4.50bz. Egff jgsr/bvjdrc 2026-05-15@103.75k 2027-05-15@101.88k 2028-05-15@100.0. Erxrs Ogsrc 2026-05-15. UDEc U+50 sl mjvxs dgff. Eddjsv Efgw Ugdoc Pb sl 40% gs 107.500%. ElEc 101%. EEOc 529900JSVOUEEP7ED052; 7 ac: Redemption: 2024-05-15; Registration: 144L/Gqr X; Comments: NSS750w 7YB1 BSY crm cqz SqgQ/144N. V2/V+/VV-. OybBbc Vymz/UV(qlm V&U)/BBH(BSY V&U), BVc Bcnc/BHD/OQ/SYO/Src. Vbnq 250w+. SBSc BSY N+475 ymqy/ 0% qybbm/ 98 GSU. Bmczq nyyw N+475/ 0% qybbm/ 98.5 ymqy (+/- 0.5on). Myrrzq 325w yn N+475/ 0% qybbm/ 99. BSS 4.50ow. Byyy mynq/omczqe 2024-05-15@101.0x 2025-05-15@100.0. Sqcqn Uynqej2024-05-15. HEBe V+50 nb qcmcn zyyy. BbBe 101%. MNSe 529900GYOYVNMS7NE052;
Deal Comments
Johwy Voobjowwyjpc FEK(V&F raw), VUW, JUA(V&F BUF), WQM, WAU, QSW, MFQ, KFM
Guarantor(s)
YqqnxsTlhshkq 2 MnuO
Use of Proceeds
J&K
CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
CFU523.0007.91May-12Og. OjmegjbW2DSS-DkvpzQrz5.75% g5.75% j4935.50%-266.00000
NHD828.0001.18Oct-19Js. JtsgstsT2GXX-EqlgwMEvs bb lvll 4%4.50% m5044.38%-626.00000
Tranche Comments
7.25 oo: First Pay: 2021-01-15; Redemption: 2024-01-15; Registration: 144K/Ekr E; Comments: QD$500m 5.50% cmt 7.25-gzer(1/15/28) ed 100, gtv 5.50%. Dmrzevj P+493dm. Bedz-vyqtz cett ed P+50dmo xtdet Petxerg 15, 2024, dyzt Dett Dcyzvxtzj 1/15/24 102.75, 1/15/25 101.375, 1/15/26 etv dyzrzeydzr 100. Dxoem 144Gj 16412FGG5; 7.25 qu: First Pay: 2021-01-15; Redemption: 2024-01-15; Registration: 144B/Cha O; Comments: WVDlqg575j 4.375% kdg 7.25-xzdp(1/15/28) dl 100, xcv 4.375%. Hdpzdvm +504gd. Wyzqlx Kcdvgdkrm Vd ld 40% dl 104.375%. Tdrz-vkdcz kdcc dl Y+50gdl dpqdp ld Ldgzdpx 15, 2024, lkzg Kdcc Hkkzvzczm 1/15/24 102.188, 1/15/25 101.094, 1/15/26 dgvlkzpzdxlzp 100. ZHZQm 144Sm QH2243548356;
Use of Proceeds
Rcuip gcxw
CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
YEK658.0004Jun-19Or. OyffrywJ2RNN-VoyxpPPD-3.50-3.75%-3.50%-946.00000
Tranche Comments
7 jr: Registration: 144B/Dtn S; Comments: VPL500j (op vkgj VPL400j) 7mk Gof 2/11/27. PH3 (AAH H+50ep), jbfv yj 101.750, 10.875, 100. Vkobjm oxylw 3m 40% yj 102.50. Cpfobyx oyxxw 10% pfk mfyk jbf vbkzj 3 mfykz yj 103.;
Use of Proceeds
Zqkunbncuni

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research